PBC News: AstraZeneca Plc’s (AZN.L) COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.
The study by the Oxford University investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the Delta and Kappa variants, the statement said.
Last week, an analysis by the Public Health England (PHE) showed that vaccines made by Pfizer Inc (PFE.N) and AstraZeneca offer high protection of more than 90% against hospitalization from the Delta variant.
The latest Oxford study results are built on the recent analysis by PHE, the company said.
The Delta variant is becoming the globally dominant version of the disease, the World Health Organization’s chief scientist said on Friday.
Probashi Barta Corporation (PBC) is a registered News media and online marketing company based in New York City, USA.
PBC24 news website considered the first Bangladeshi online news portal; established in November 2003. It was called www.probashibarta.com at that time and formed the corporation in 2007. Like any other business PBC discontinued for several years for unavoidable circumstances. Recently PBC24.com came back to serve the community again. We are blessed and humble with the love of the people worldwide. Thank you for visiting www.PBC24.com
Chief Editor & publisher : MOTIUR RAHMAN (Litu),
News editor: Mahbubur Rahman (Titu)
Advisor: Mohammad Zainal Abedin
All rights reserved @ Probashi Barta Corporation, USA